DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Art Pappas will participate on a panel called "Venture Capital and Private Equity - How Do You Look for the Next Big Investment" at the Drug Delivery Partnerships conference in Las Vegas, NV
News | 01. 22. 2009
